Ceptur Therapeutics logo

Ceptur Therapeutics

ID: 12272799

Ceptur Therapeutics is Revolutionizing RNA Therapeutics with U1 Adaptor Technology to Develop Medicines for Unaddressed Diseases

2

Funding Rounds

$150.0m

Money raised

Overview

Ceptur Therapeutics is Revolutionizing RNA Therapeutics with U1 Adaptor Technology to Develop Medicines for Unaddressed Diseases

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding series

Funding Series Analysis

The company Ceptur Therapeutics has raised a total of $150m in funding over 2 rounds.

Key Insights:

  • Ceptur Therapeutics Funding Round, March 2022: $75m
  • Ceptur Therapeutics Series A round, January 2022: $75m

Industries

Ceptur Therapeutics is active in the following industries: